BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32159067)

  • 1. Locally Aggressive Giant Cell Tumor of Bone With Pulmonary Distant Metastasis and Extrapulmonary Seeding in Pregnancy.
    Murshed KA; Elsayed AM; Szabados L; Rashid S; Ammar A
    J Am Acad Orthop Surg Glob Res Rev; 2020 Jan; 4(1):. PubMed ID: 32159067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symplastic/pseudoanaplastic giant cell tumor of the bone.
    Sarungbam J; Agaram N; Hwang S; Lu C; Wang L; Healey J; Hameed M
    Skeletal Radiol; 2016 Jul; 45(7):929-35. PubMed ID: 27020452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
    Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
    Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.
    Yamamoto H; Ishihara S; Toda Y; Oda Y
    Med Mol Morphol; 2020 Mar; 53(1):1-6. PubMed ID: 31748824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postpartum Treatment of Metastatic Recurrent Giant Cell Tumor of Capitate Bone of Wrist.
    Satcher RL; Ravi V; Wang WL; Oates S
    Am J Orthop (Belle Mead NJ); 2017; 46(4):E269-E275. PubMed ID: 28856360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
    BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent primary giant cell tumour of the proximal radius with pulmonary metastases.
    Ropars M; Siret P; Kaila R; Duval H; Dréano T
    Joint Bone Spine; 2008 Dec; 75(6):740-1. PubMed ID: 18619891
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.
    Tsukamoto S; Righi A; Vanel D; Honoki K; Donati DM; Errani C
    Jpn J Clin Oncol; 2017 Nov; 47(11):1090-1096. PubMed ID: 29048579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Preoperative CT and MR Imaging Findings in the Prediction of Postoperative Recurrence of Spinal Giant Cell Tumor of Bone.
    Wang QZ; Zhang EL; Xing XY; Su MY; Lang N
    Orthop Surg; 2021 Dec; 13(8):2405-2416. PubMed ID: 34841660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.
    Yamamoto H; Iwasaki T; Yamada Y; Matsumoto Y; Otsuka H; Yoshimoto M; Kohashi K; Taguchi K; Yokoyama R; Nakashima Y; Oda Y
    Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
    Kato I; Furuya M; Matsuo K; Kawabata Y; Tanaka R; Ohashi K
    Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
    Lüke J; von Baer A; Schreiber J; Lübbehüsen C; Breining T; Mellert K; Marienfeld R; Schultheiss M; Möller P; Barth TFE
    Histopathology; 2017 Jul; 71(1):125-133. PubMed ID: 28211081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant cell tumor: a case report of recurrence during pregnancy.
    Ross AE; Bojescul JA; Kuklo TR
    Spine (Phila Pa 1976); 2005 Jun; 30(12):E332-5. PubMed ID: 15959356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone.
    Amary F; Berisha F; Ye H; Gupta M; Gutteridge A; Baumhoer D; Gibbons R; Tirabosco R; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2017 Aug; 41(8):1059-1068. PubMed ID: 28505000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary metastasis of giant cell tumor of bones.
    Muheremu A; Niu X
    World J Surg Oncol; 2014 Aug; 12():261. PubMed ID: 25139054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An eggshell-like mineralized recurrent lesion in the popliteal region after treatment of giant cell tumor of the bone with denosumab.
    Akaike K; Suehara Y; Takagi T; Kaneko K; Saito T
    Skeletal Radiol; 2014 Dec; 43(12):1767-72. PubMed ID: 25052539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases.
    Miller IJ; Blank A; Yin SM; McNickle A; Gray R; Gitelis S
    Diagn Pathol; 2010 Sep; 5():62. PubMed ID: 20860830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.
    Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V
    Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
    Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiological findings of denosumab treatment for giant cell tumours of bone.
    van Langevelde K; McCarthy CL
    Skeletal Radiol; 2020 Sep; 49(9):1345-1358. PubMed ID: 32335707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.